Immunostimulatory mesoporous silica nanoparticles (immuno-MSN) carrying cyclic diguanylate monophosphate (cdGMP) and STING agonist were systemically delivered and facilitated circulating CD8+ T-cell activity and delayed tumour growth in a mouse GBM model [37]. The gene discussed is CD8A; the disease is glioblastoma.